title: HIV vaccines: an attainable goal?
abstract: Publication of the first efficacious large-scale HIV vaccine trial in 2009 prompted fresh hope that design of a protective vaccine against HIV may be achievable. In this review we explore the difficult task of eliciting protective immune responses to HIV and highlight the hurdles that vaccine design must still overcome.
authors.affiliation: Institute of Medical Virology, University of Zurich, Switzerland. reynell.lucy@virology.uzh.ch
authors.forename: Lucy
authors.initials: L
authors.lastname: Reynell
authors.forename: Alexandra
authors.initials: A
authors.lastname: Trkola
mesh_terms: D016915:AIDS Vaccines / Q000627:therapeutic use*; D000818:Animals; D015195:Drug Design; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D056724:Immunity, Humoral
chemical_list: D016915:AIDS Vaccines